Results 111 to 120 of about 4,105 (201)

Derivation of human post-mitotic cardiomyocytes from tetraploid iPSCs. [PDF]

Commun Biol
Nakajima I, Shimane M, Holmstrom G, Miyaoka Y.   +3 more
europepmc   +1 more source

Advancing Torsades de pointes risk prediction: unveiling the role of drug metabolites through molecular docking. [PDF]

Toxicol Res (Camb)
Bilgin E, Tugcu G, Aydin A.
europepmc   +1 more source

Improving Speed and Efficiency of DESI Imaging with the Xevo MRT Mass Spectrometer for Analyte Mapping. [PDF]

Metabolites
Towers M, Claude E, Towers L, Yates H, Ballantyne J.   +4 more
europepmc   +1 more source

Effect of diosmectite on the pharmacokinetics of osimertinib in rats. [PDF]

Sci Rep
He G, Wu J, Bi Y, Fu C, Yang Y, Zu Y, Huo D, Yu J.   +7 more
europepmc   +1 more source

Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-<i>Trypanosoma cruzi</i> Agents: An In Silico and In Vitro Approach. [PDF]

Molecules
Vázquez-Jiménez LK, González-González A, Delgado-Maldonado T, Gómez-Escobedo R, Avalos-Navarro G, Moreno-Rodríguez A, Paz-González AD, Ortiz-Pérez E, Nogueda-Torres B, Rivera G.   +9 more
europepmc   +1 more source

Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment. [PDF]

Pharmaceuticals (Basel)
Alas-Pineda C, Pavón-Varela DJ, Gaitán-Zambrano K, Ferrer G.   +3 more
europepmc   +1 more source

Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models. [PDF]

J Chem Inf Model
Sun H, Wang Y, Shen M.
europepmc   +1 more source

DCPM-ADMET: fusion of dual-component pre-trained model and molecular fingerprints to enhance drug ADMET properties prediction. [PDF]

J Cheminform
Zhang L, Zeng Y, Qi Y, Jiang K, Zhou X, Liang L, Lin J.   +6 more
europepmc   +1 more source

An Unusual Genetic Variant of Long QT Syndrome with Late Presentation in the Sixth Decade. [PDF]

J Innov Card Rhythm Manag
Pande A, Mukherjee SS, Halder A.
europepmc   +1 more source

Clinical trials in a dish: cardiometabolic drug development with biological and digital twins. [PDF]

J Clin Invest
Patra D, Sayed IM, Venkateshappa R, Palaniappan L, McLaughlin T, Wu JC.   +5 more
europepmc   +1 more source